NCT00337350
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +5 more
- Locations
-
- Massachusetts General Hospital Schizophrenia Program Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.
NCT00337350
NCT01852331
NCT01432444
NCT00103727
NCT00677898
NCT01157351
NCT00144027
NCT00466323
NCT00297947
NCT00312949